Clinical trial
Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer
NCT00350142 · Albert Koong, Other · Completed
Key facts
| NCT number | NCT00350142 |
|---|---|
| Title | Trilogy Stereotactic Body Radiotherapy for Pancreatic Cancer |
| Official title | Phase II Study to Evaluate the Efficacy of Trilogy Stereotactic Radiosurgery for Pancreatic Cancer |
| Lead sponsor | Albert Koong, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Pancreatic Cancer |
| Intervention type | Drug, Other, Radiation |
| Interventions | Stereotactic Body Radiotherapy, Gemcitabine, 4D pancreatic protocol CT scan, FDG PET scan |
| Enrollment | 20 |
| Start date | Apr 1, 2006 |
| Primary completion | Oct 1, 2008 |
| Completion | Oct 1, 2008 |
| First posted | Jul 10, 2006 |
| Last update posted | Feb 14, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: